14.55
Greenwich Lifesciences Inc Borsa (GLSI) Ultime notizie
Precision Trading with Greenwich Lifesciences Inc. (GLSI) Risk Zones - Stock Traders Daily
Precision Trading with Greenwich Lifesciences Inc. (GLSI) Risk Zones - Stock Traders Daily
HER2-Positive Breast Cancer Pipeline 2026: Key Developments, Emerging Therapies, and Clinical Trials Detailed Analysis by DelveInsight | Roche Pharma AG, Dizal Pharma, Greenwich LifeSciences, Ambrx - StreetInsider
Understanding Momentum Shifts in (GLSI) - Stock Traders Daily
Greenwich Lifesciences Inc (GLSI-Q) Stock Price and News - The Globe and Mail
Greenwich LifeSciences (GLSI) Short Interest & Short Float | Updated Oct 2026 $GLSI - MarketBeat
Behavioral Patterns of GLSI and Institutional Flows - Stock Traders Daily
Why (GLSI) Price Action Is Critical for Tactical Trading - Stock Traders Daily
One Greenwich LifeSciences Insider Raised Their Stake In The Previous Year - simplywall.st
Greenwich LifeSciences (GLSI) Slips 1.40% to $14.74, Holds Above Key SupportStock Picks - dars.gov.et
Understanding the Setup: (GLSI) and Scalable Risk - Stock Traders Daily
Why is Greenwich LifeSciences stock rallying today? - Investing.com
Why is Greenwich LifeSciences stock rallying today? - Investing.com
Greenwich (GLSI) Earnings Check: EPS Misses Its Estimate under the Current Snapshot; Post-Earnings Trading: The Share Price Sheds 0.69% on the DayAnnual Financial Report - vinanet.vn
Greenwich Lifesciences Stock Price Forecast. Should You Buy GLSI? - StockInvest.us
Greenwich Lifesciences Inc (NASDAQ: GLSI) Share Price, GLSI Stock News, GLSI Share Price & Updates - Kalkine
GLSI Q1 2026 Earnings: Wider-than-Expected Loss Reflects Clinical-Stage R&D InvestmentEarnings Revision Downgrade - vinanet.vn
Greenwich Lifesciences Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Greenwich LifeSciences (NASDAQ:GLSI) Posts Quarterly Earnings Results - MarketBeat
Greenwich LifeSciences 2Q 2026: Revenue $0 Net loss $(3.95M), EPS $(0.27) — 10-Q Summary - TradingView
Greenwich LifeSciences | 10-Q: Q2 2026 Earnings Report - Moomoo
Greenwich LifeSciences, Inc. (GLSI) stock price, news, quote and history - Yahoo Finance Singapore
Greenwich LifeSciences (GLSI) posts higher H1 2026 loss and flags going concern risk - Stock Titan
Greenwich Lifesciences Inc expected to post a loss of 33 cents a shareEarnings Preview - TradingView
Responsive Playbooks and the GLSI Inflection - Stock Traders Daily
Greenwich LifeSciences Extends Insider and Pre-IPO Share Lock-Up to January 31, 2027 - Quiver Quantitative
Greenwich LifeSciences Directors, Officers Face 100% Lock-Up to 2027 - Stock Titan
Greenwich LifeSciences Extends Lock-up of Directors and Officers to January 31, 2027 - globenewswire.com
Greenwich LifeSciences (GLSI) Expected to Post Earnings on Thursday - MarketBeat
Understanding the Setup: (GLSI) and Scalable Risk - Stock Traders Daily
Form 4 Greenwich Lifesciences Inc For: 30 July By Investing.com - Investing.com Nigeria
Greenwich LifeSciences CEO Snehal Patel buys $29,555 in stock By Investing.com - Investing.com Nigeria
Form 4 Greenwich Lifesciences Inc For: 30 July By Investing.com - Investing.com Canada
Greenwich LifeSciences CEO Snehal Patel buys $29,555 in stock By Investing.com - Investing.com Canada
Greenwich LifeSciences CEO Snehal Patel buys $29,555 in stock - Investing.com
Greenwich LifeSciences CEO Snehal Patel buys $20,430 in shares By Investing.com - Investing.com UK
Greenwich LifeSciences CEO Snehal Patel buys $20,430 in shares By Investing.com - Investing.com Nigeria
Greenwich LifeSciences CEO Snehal Patel buys $20,430 in shares By Investing.com - Investing.com South Africa
Form 4 Greenwich Lifesciences Inc For: 29 July By Investing.com - Investing.com Canada
Greenwich LifeSciences CEO Snehal Patel buys $20,430 in shares By Investing.com - Investing.com Canada
Greenwich LifeSciences CEO Snehal Patel buys $20,430 in shares - investing.com
Greenwich LifeSciences (NASDAQ:GLSI) CEO Snehal Patel Purchases 2,500 Shares - MarketBeat
Greenwich Lifesciences Inc (GLSI) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey
Form 4 Greenwich Lifesciences Inc For: 27 July By Investing.com - Investing.com Nigeria
Form 4 Greenwich Lifesciences Inc For: 27 July By Investing.com - Investing.com Canada
Form 4 Greenwich Lifesciences Inc For: 27 July By Investing.com - Investing.com UK
Greenwich LifeSciences CEO buys $47,018 in company stock By Investing.com - Investing.com Canada
Greenwich LifeSciences CEO buys $47,018 in company stock - Investing.com
Greenwich LifeSciences (NASDAQ: GLSI) CEO adds 3,600 shares in open-market buys - Stock Titan
Greenwich LifeSciences CEO buys $47,018 in company stock - investing.com
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):